Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sera Prognostics (SERA) Cash & Equivalents (2020 - 2025)

Sera Prognostics' Cash & Equivalents history spans 6 years, with the latest figure at $3.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 2.45% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $3.9 million, down 2.45%, while the annual FY2025 figure was $3.9 million, 2.45% down from the prior year.
  • Cash & Equivalents reached $3.9 million in Q4 2025 per SERA's latest filing, down from $4.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $90.9 million in Q2 2021 to a low of $2.7 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $27.7 million, with a median of $9.7 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: surged 335.47% in 2021, then tumbled 87.01% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $58.9 million in 2021, then crashed by 49.3% to $29.9 million in 2022, then crashed by 87.01% to $3.9 million in 2023, then rose by 4.2% to $4.0 million in 2024, then fell by 2.45% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for SERA's Cash & Equivalents are $3.9 million (Q4 2025), $4.1 million (Q3 2025), and $5.0 million (Q2 2025).